Navigation mit Access Keys

Search


Congenital muscle weakness: Muscles fail to regenerate

Roughly eight in every million children are born with a particularly severe form of muscle weakness known as LAMA2-related muscular dystrophy. In Switzerland, 18 cases are currently known. This rare hereditary disease is…


Biozentrum Symposium 2025: A day dedicated to science

In a refreshing change of scenery, the researchers of our institute stepped out of their labs and gathered at the uptown Basel area for the 2025 Biozentrum Symposium. This year’s organizing committee, headed by Prof. Silvia…


Incurable muscle disease: First successes in the development of a gene therapy

Roughly once a year in Switzerland, a family receives the devastating diagnosis that their child is affected by a severe form of muscle weakness. This hereditary disease, known as LAMA2-related muscular dystrophy, is very…


Designed proteins to treat muscular dystrophy

Muscular dystrophy is a term used to describe many different muscular diseases caused by genetic defects. To date, there are no treatments available to stop disease progression. In their study, the scientists led by Prof.…


EMBO Membership for Alex Schier

As EMBO announced on May 14, 2018, Prof. Alex Schier is now a newly elected EMBO member. Including Alex Schier a total of 26 scientists have been recognized for their achievements with an EMBO Membership since the foundation…


Great community events: Biozentrum Symposium and first World Alumni Day

Biozentrum Symposium 2023 On Thursday, June 22, the Biozentrum Symposium took place, this time in the beautiful Kunstmuseum Basel - bringing together art and science. This symposium was a great opportunity for our…


Highlights 1971 - 2021

Biozentrum Highlights 1971 - 2021 1968 − Pioneering concept The potential of molecular biology was recognized early in Switzerland – in the 1960s. Due to the visionary leadership of Arnold Schneider, a member of the Cantonal…


CV

CV of Prof. Dr. Markus A. Ruegg ORCID 0000-0002-4974-9384 Nationality : Swiss Positions: Since 2021 – Co-founder and CEO of SEAL Therapeutics Ltd. Weblink Since 2004 – Full Professor of Neurobiology 1998 – 2004 Associate…


CV

CV of Prof. Dr. Knut Drescher ORCID 0000-0002-7340-2444 Google Scholar Google Scholar Positions: Since 2021 Associate Professor at the Biozentrum 2015 - 2021 Professor of Biophysics, Philipps-Universität Marburg 2014 - 2021…


Biozentrum PhD Fellowships: Application deadline December 15

"The Biozentrum is an institute that has always attracted good researchers. However, with the Biozentrum PhD Fellowships program, we have a unique tool to also actively recruit outstanding, international junior scientist,"…